Betsy A Bussdieker, MA, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 600 Bassett St, Toledo, OH 43611 Phone: 419-671-6650 |
Lauren Zimmerman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3160 Central Park W, Toledo, OH 43617 Phone: 419-841-1840 Fax: 419-841-1841 |
Carrie L Snare Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 131 N Wheeling St, Toledo, OH 43605 Phone: 419-724-2638 |
Corinne Marie Harris Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3939 Wrenwood Rd, Toledo, OH 43623 Phone: 419-671-5199 |
Ms. Tracy R. Huff, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5510 Greenridge Dr, Toledo, OH 43615 Phone: 419-865-5951 Fax: 419-867-9299 |
Lisa Simon, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3281 Upton Ave Rm 2226, Toledo, OH 43613 Phone: 419-671-8724 |
Stacy Geissler, MC/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3148 W Central Ave, Toledo, OH 43606 Phone: 419-241-6219 Fax: 419-241-5912 |
Mrs. Kimberly Rene Schumacher, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7120 Port Sylvania Dr, Toledo, OH 43617 Phone: 419-841-2200 Fax: 419-841-2822 |
Jennifer Royer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3450 W Central Ave, Ste, Toledo, OH 43606 Phone: 419-536-4247 |
Allison Lohse Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5050 Douglas Rd, Toledo, OH 43613 Phone: 419-473-8218 |
Kathryn Cendrowski Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3450 W Central Ave Ste 336, Toledo, OH 43606 Phone: 419-536-4247 Fax: 419-537-1738 |
Enhancing Communication Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2332 Newport Ave, Toledo, OH 43613 Phone: 567-218-0518 Fax: 567-200-8433 |
Northwest Ohio Speech Language And Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3450 W Central Ave, Suite 336, Toledo, OH 43606 Phone: 419-536-4247 |
Rachel Glass, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5331 Bennett Rd, Toledo, OH 43612 Phone: 419-671-9226 |
Katharine Pederson Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3450 W Central Ave Ste 336, Toledo, OH 43606 Phone: 419-536-4247 |
Debra L Katz, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4606 Waterford Ct, Toledo, OH 43623 Phone: 419-704-8672 |
Melissa Clark Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3450 W Central Ave Ste 336, Toledo, OH 43606 Phone: 419-536-4247 |
Charisse Toeppe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3450 W Central Ave Ste 336, Toledo, OH 43606 Phone: 419-536-4247 |
Mrs. Wendy Lynn Pauly, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 550 Raymer Blvd, Toledo, OH 43605 Phone: 419-671-7650 |
Miss Jennifer N Mcdaniel, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 955 Garden Lake Pkwy, Toledo, OH 43614 Phone: 419-382-2200 Fax: 419-381-1088 |
News Archive
California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
At a morning ceremony today, New York City Council Member James Vacca, along with administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University, celebrated the re-launch of Einstein's Gruss Magnetic Resonance Research Center.
A public/private collaboration led by researchers at The University of Texas at Austin has resulted in a new mathematical modeling technique that can accurately predict the response of tumors in breast cancer patients to treatments such as chemotherapy soon after treatment initiation.
An antiparasitic agent used to treat African sleeping sickness might someday be used to prevent nonmelanoma skin cancers. Researchers found that DFMO, or α-difluoromethylornithine, still appeared to protect against nonmelanoma skin cancers years after people stopped taking the drug, according to a poster presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.
› Verified 1 days ago